Despesas Operacionais Alterar Data
AstraZeneca USD 11.55B 674M 2026-09
Genmab DKK 748M 77M 2026-06
GlaxoSmithKline GBP 6.03B 227M 2026-09
GRIFOLS EUR 1.65B 101M 2026-09
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Lakefront Biotherapeutics EUR 55.62M 14.56M 2026-06
Qiagen NV USD 393.64M 17.95M 2026-06
UCB EUR 2.96B 196M 2025-12